The structural and functional characteristics of TNFR-1/CD120a protein

TNFR-1/CD120a protein is a typical member of the tumor necrosis factor receptor superfamily, with its gene located on the short arm of human chromosome 12. This protein consists of 455 amino acid residues, with a theoretical molecular weight of approximately 55 kilodaltons, and belongs to the type I transmembrane glycoprotein family. Structurally, TNFR-1 comprises three main functional regions: the extracellular domain, transmembrane domain, and intracellular domain. The extracellular domain is rich in cysteine residues, forming four characteristic cysteine-rich domains, each folded from approximately 40 amino acids and stabilized by intrachain disulfide bonds. The transmembrane domain consists of 21 hydrophobic amino acids, anchoring the protein to the cell membrane. The intracellular domain contains an approximately 80-amino-acid death domain, which plays a central role in mediating apoptotic signals. Crystal structure analysis reveals that the extracellular domain of TNFR-1 adopts an elongated cylindrical conformation, facilitating its recognition and binding to ligand molecules.

The primary physiological ligand of TNFR-1 is tumor necrosis factor-alpha (TNF-α), though it can also recognize tumor necrosis factor-beta (TNF-β). The interaction between ligand and receptor follows a characteristic trimeric pattern, where one homotrimeric TNF-α molecule simultaneously binds three TNFR-1 molecules. This binding induces conformational changes in the receptor, exposing the intracellular death domain and recruiting downstream signaling molecules. Affinity measurements indicate that the dissociation constant between TNFR-1 and TNF-α is in the sub-nanomolar range, reflecting their high-affinity, specific recognition. Additionally, soluble forms of TNFR-1 can compete with membrane-bound receptors for ligand binding sites, thereby modulating signaling. Structural biology studies further reveal that ligand binding primarily relies on the second and third cysteine-rich domains of the extracellular region, with multiple aromatic amino acid residues participating in hydrophobic interaction networks.

Upon activation by its ligand, TNFR-1 primarily transmits biological signals through two classical pathways. The first is the nuclear factor kappa B (NF-κB) pathway, whose activation depends on the sequential recruitment of adaptor proteins and receptor-interacting protein kinases by the intracellular death domain. This pathway promotes cell survival, proliferation, and the transcriptional expression of inflammatory factors. The second is the apoptosis pathway, initiated when caspase-8 is recruited to the receptor complex and undergoes autocleavage activation. The balance between these two pathways is finely regulated by multiple factors, including cell type, ligand concentration, and the expression levels of auxiliary proteins. Notably, TNFR-1 can also mediate programmed necrosis, a specialized form of cell death dependent on the phosphorylation of receptor-interacting protein kinase 3 (RIPK3). The dynamic assembly and disassembly of signaling complexes are critical nodes determining cell fate, with various regulatory proteins participating in spatiotemporal control.

TNFR-1 exhibits widespread tissue distribution in the body, with detectable expression in immune cells, endothelial cells, hepatocytes, and neuronal cells. Its expression levels are jointly regulated by transcription factors, inflammatory mediators, and epigenetic modifications. Under physiological conditions, cell-surface TNFR-1 expression remains at relatively low baseline levels. When tissues are exposed to inflammatory stimuli or oxidative stress, the protein's transcriptional activity rapidly increases. Metalloproteinases can cleave the extracellular domain of membrane-bound TNFR-1, releasing biologically active soluble fragments into systemic circulation—a shedding mechanism that serves as an important negative feedback regulation of receptor expression. Additionally, endocytosis plays a regulatory role in the spatial distribution and signal transduction of the receptor, with different endocytic pathways potentially leading to distinct signaling outcomes.

TNFR-1-mediated signaling pathways participate in the regulation of various physiological processes, including immune responses, inflammatory reactions, cell proliferation and differentiation, and tissue homeostasis maintenance. During embryonic development, this receptor is indispensable for the formation of lymphoid organs and the establishment of the immune system. From a pathophysiological perspective, abnormal activation of TNFR-1 signaling is closely associated with the onset and progression of multiple diseases. Excessive and sustained inflammatory signaling can lead to tissue damage, while dysregulation of apoptotic signaling may contribute to the pathogenesis of autoimmune diseases. Given its central role in inflammatory networks, strategies targeting the regulation of TNFR-1 signaling have become a key focus in basic research. Animal model studies further confirm that TNFR-1-deficient individuals exhibit enhanced resistance to certain inflammatory injuries, providing direct evidence for understanding the protein's functions.

Current research on TNFR-1 has gradually expanded from purely elucidating signal transduction mechanisms to resolving the three-dimensional structure and dynamic conformational changes of receptor complexes. Single-molecule imaging techniques and cryo-electron microscopy provide powerful tools for revealing the intricate processes of receptor activation. Future studies need to further clarify the cell-type-specific functions of TNFR-1 and its mechanisms for maintaining systemic homeostasis. Simultaneously, developing highly selective receptor activity modulators is an important direction for translational research, offering new tools for deeper insights into the biological functions of TNFR-1.

Nanjing UA-Bio Technology Co., Ltd. (UA-Bio) has independently developed "TNFR-1/CD120a Protein, Human" (Catalog No.: UA040030), a high-quality recombinant protein reagent specifically designed for tumor necrosis factor receptor signaling pathway research and targeted drug development. This protein is human tumor necrosis factor receptor 1 (TNFR-1), a key membrane receptor for TNF-α-induced apoptosis and inflammatory responses. It binds with high affinity to TNF-α trimers, activating downstream NF-κB and caspase signaling pathways, providing a stable and reliable standardized tool for exploring autoimmune disease mechanisms, anti-inflammatory drug screening, and biosimilar activity evaluation.

Nanjing UA-Bio Technology Co., Ltd. is committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding "TNFR-1/CD120a Protein, Human" (Catalog No.: UA040030), please feel free to contact us.